These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11689283)

  • 1. Protective autoimmunity as a T-cell response to central nervous system trauma: prospects for therapeutic vaccines.
    Schwartz M
    Prog Neurobiol; 2001 Dec; 65(5):489-96. PubMed ID: 11689283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective autoimmunity: regulation and prospects for vaccination after brain and spinal cord injuries.
    Schwartz M; Kipnis J
    Trends Mol Med; 2001 Jun; 7(6):252-8. PubMed ID: 11378514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response.
    Kipnis J; Yoles E; Schori H; Hauben E; Shaked I; Schwartz M
    J Neurosci; 2001 Jul; 21(13):4564-71. PubMed ID: 11425884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective autoimmunity against the enemy within: fighting glutamate toxicity.
    Schwartz M; Shaked I; Fisher J; Mizrahi T; Schori H
    Trends Neurosci; 2003 Jun; 26(6):297-302. PubMed ID: 12798598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell cytokines in injury-induced neural damage and repair.
    Schroeter M; Jander S
    Neuromolecular Med; 2005; 7(3):183-95. PubMed ID: 16247179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell-based therapeutic vaccination for spinal cord injury.
    Schwartz M; Hauben E
    Prog Brain Res; 2002; 137():401-6. PubMed ID: 12440382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological approaches to neuroprotection. boosting of protective autoimmunity.
    Schwartz M
    Surv Ophthalmol; 2001 May; 45 Suppl 3():S256-60; discussion S273-6. PubMed ID: 11377445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nervous system and non-central nervous system antigen vaccines exacerbate neuropathology caused by nerve injury.
    Ankeny DP; Popovich PG
    Eur J Neurosci; 2007 Apr; 25(7):2053-64. PubMed ID: 17439492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of autoimmunity on recovery of function in adult rats following spinal cord injury.
    Lü HZ; Xu L; Zou J; Wang YX; Ma ZW; Xu XM; Lu PH
    Brain Behav Immun; 2008 Nov; 22(8):1217-30. PubMed ID: 18625299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmunity: basic mechanisms and implications in endocrine diseases. Part II.
    Ballotti S; Chiarelli F; de Martino M
    Horm Res; 2006; 66(3):142-52. PubMed ID: 16807509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harnessing the immune system for neuroprotection: therapeutic vaccines for acute and chronic neurodegenerative disorders.
    Schwartz M
    Cell Mol Neurobiol; 2001 Dec; 21(6):617-27. PubMed ID: 12043837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell mediated neuroprotection is a physiological response to central nervous system insults.
    Schwartz M
    J Mol Med (Berl); 2001; 78(11):594-7. PubMed ID: 11269506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial immune activity after CNS injury: prospects for vaccination.
    Schwartz M; Moalem G
    J Neuroimmunol; 2001 Feb; 113(2):185-92. PubMed ID: 11164901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does inflammation in an autoimmune disease differ from inflammation in neurodegenerative diseases? Possible implications for therapy.
    Schwartz M; Butovsky O; Kipnis J
    J Neuroimmune Pharmacol; 2006 Mar; 1(1):4-10. PubMed ID: 18040786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concept of autoimmunity following spinal cord injury: possible roles for T lymphocytes in the traumatized central nervous system.
    Popovich PG; Stokes BT; Whitacre CC
    J Neurosci Res; 1996 Aug; 45(4):349-63. PubMed ID: 8872895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune T cells as potential neuroprotective therapy for spinal cord injury.
    Hauben E; Nevo U; Yoles E; Moalem G; Agranov E; Mor F; Akselrod S; Neeman M; Cohen IR; Schwartz M
    Lancet; 2000 Jan; 355(9200):286-7. PubMed ID: 10675079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid induction of autoantibodies against Nogo-A and MOG in the absence of an encephalitogenic T cell response: implication for immunotherapeutic approaches in neurological diseases.
    Merkler D; Oertle T; Buss A; Pinschewer DD; Schnell L; Bareyre FM; Kerschensteiner M; Buddeberg BS; Schwab ME
    FASEB J; 2003 Dec; 17(15):2275-7. PubMed ID: 14563689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic T cell-based vaccination for neurodegenerative disorders: the role of CD4+CD25+ regulatory T cells.
    Schwartz M; Kipnis J
    Ann N Y Acad Sci; 2005 Jun; 1051():701-8. PubMed ID: 16127010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective autoimmunity is a physiological response to CNS trauma.
    Yoles E; Hauben E; Palgi O; Agranov E; Gothilf A; Cohen A; Kuchroo V; Cohen IR; Weiner H; Schwartz M
    J Neurosci; 2001 Jun; 21(11):3740-8. PubMed ID: 11356861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune maintenance and neuroprotection of the central nervous system.
    Cohen IR; Schwartz M
    J Neuroimmunol; 1999 Dec; 100(1-2):111-4. PubMed ID: 10695721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.